Neonatal Seizures: - Dr.C.S.N.Vittal
Neonatal Seizures: - Dr.C.S.N.Vittal
Neonatal Seizures: - Dr.C.S.N.Vittal
Seizures
• Dr.C.S.N.Vittal
DEFINITIONS
SEIZURE:
• A seizure is a paroxysmal behavior caused by hypersynchronous discharge of a
group of neurons.
NEONATAL SEIZURE:
• Neonatal seizures may be defined more aptly as paroxysmal alterations
in neurologic function (eg, behavioral, motor, or autonomic function).
Neonatal seizures are the most common overt manifestation of neurological dysfunction in the newborn.
Pathophysiology
• Immature brain has many differences from the mature brain that
render it more excitable and more likely to develop seizures.
• Delay in Na+ , K+ -adenosine triphosphatase maturation and
increased NMDA and α-amino-3-hydroxy-5-methylisoxazole-4-
propionate (AMPA) receptor density.
• Delay in the development of inhibitory GABAergic transmission
• GABA in the immature brain has an excitatory function
CAUSES OF NEONATAL SEIZURES
Infections (5-20%)
Metabolic (7-20%)
Genetic (6-10%)
Hypoxic-Ischemic Unknown/ Other (10%)
Encephalopathy
Infections
Brain
Malformations
Genetic Metabolic
Infarction &
Hemorrhage
Neonatal Seizures - Types
01
Subtle
02
Clonic
03
Tonic
04
Spasms
05
Myoclonic
01
1 Subtle Seizures
2 Clonic Seizures
• Focal:
• Involve face upper + /- lower extremities on
• one site “axial structures (neck / trunk)
• Usually associated with neuropathology (i.e. Cerebral infarction and intra
cerebral haemorrhage)
• Multi focal:
• Involve several body parts and often
• migrate in a non-jacksonian (random) manner may also involve the face.
• Consider the neonatal equivalent of generalized tonic – clonic seizures.
03
3 Tonic Seizures
• Focal :
• Sustained posturing of a limb or
• Asymmetric posturing of the trunk and / or neck
• Generalized :
• Decerebrate posturing
• Decorticate posturing
• Usually associated with apnoea and upward gaze of eyes
• Most common in preemies and usually
• indicates structural brain damage and IVH
04
4 Spasms
• Jitteriness – Tremor
• No associated ocular movements or autonomic phenomena,
• Stimulus sensitivity,
• Tremor that is suppressed by flexing the limb.
• Benign neonatal sleep myoclonus
• Occurs in healthy newborns
• Only during sleep. Jerking ceases on wakening
• Apnea of prematurity
• In Preterms, apnea and bradycardia
Diagnosis
- History: Maternal drug abuse, Intrauterine infection, metabolic disease,
natal history, etc.
- Complete Hemogram
- Blood : Sugar, Calcium, Magnesium, Na+, K+ & HCO3 , Elevated
Ammonia, Lactate Levels, Culture & Sensitivity, plasma
aminoacids, drugs
- CSF :Analysis, Biochemical & C/s.
- Cranial U/s. : hemorrhage, cysts, abnormal ventricles
- EEG :Plays an important role
Diagnosis - EEG
• Continuous electroencephalogram (cEEG): >3 hours of monitoring is
gold standard for the diagnosis of neonatal seizures
• Including video analysis can be very helpful
• Routine neonatal EEG recording, typically of 1 hour duration, allows
assessment of background activity, including cycling state change,
developmental maturity, and sometimes, epileptic potential.
• Amplitude-integrated electroencephalogram (aiEEG): a bedside
technique increasingly being used by neonatologists for
neuromonitoring
MANAGEMENT OF NEONATAL SEIZURES - ACUTE
PHASE
Aim: prevent brain injury
• GENERAL MEASURES :
• OPTIMISE:Ventilation, Circulation, Electrolytes, Acid-Base Balance
• NONEPILEPTIC EVENTS : Associated with No EEG Seizure Activity.
• These Types of Neonatal Seizures Should not be Treated.
• EPILEPTIC EVENTS: Associated with EEG Seizure Activity
MANAGEMENT: - Correct metabolic disturbances.
Hypoglycemia:
• (10% glucose in water) 2 mL/kg IV (0.2 g/kg) as bolus .
Follow with continuous infusion at up to 8 mg/kg/min IV
MANAGEMENT: - Correct metabolic disturbances.
Hypocalcemia:
• Calcium gluconate 10%: 100 mg/kg IV mixed with equal amount of
10% dextrose given by slow I.V. over 1 to 3 minutes
• Note: Monitor cardiac rhythm for bradycardia
• Follow with maintenance of 500 mg/kg/24 hrs IV or PO
Hypomagnesemia:
• Magnesium sulfate - 25-250 mg/kg/dose IV/IM (50% magnesium
sulphate 0.2 ml/kg)
Management: - Anticonvulsant therapy.
1.Phenobarbital: 20 mg/kg IV. If necessary, additional 10-20 mg/kg IV in 10 mg/kg aliquots
Maintenance: 4–6 mg/kg/24 hrs IV/PO
If 40 mg/kg of Phenobarbital is not effective, >>
2. Lorazepam: 0.05 mg/kg to 0.10 mg/kg IV in 0.05 mg/kg increments over several minutes.
• (Inj. Clonzepam Loading dose of 0.25 mg/kg followed by 0.01 to 0.03 mg/kg/orally given (or)
• Inj. Midazolam 0.02 to 0.1 mg/kg - I.V. can be given )
3. Phenytoin: 20 mg/kg IV (diluted in 0.9% NaCl) (Maximal rate: 1 mg/kg/min.
Monitor cardiac rate and rhythm). Maintenance 5–10 mg/kg/24h IV
5. Fourth line anticonvulsants include Paraldehyde